The Robotic Prostatectomy Took Place at Apollo Hospitals,
Greams Road, Chennai,
India
DUBLIN and CHENNAI, India, Sept.
27, 2021 /CNW/ -- Medtronic plc (NYSE:MDT) and Apollo
Hospitals Group today announced the first clinical procedure in
Asia-Pacific with the Hugo™
robotic-assisted surgery (RAS) system. The robotic prostatectomy
was performed on September 17 by Dr.
N Ragavan, consultant urologist, uro-oncologist and robotic
surgeon, at Apollo Hospitals, Greams Road, Chennai, India.
"Here in India, nearly 70% of
surgeries are performed as open procedures1 — we feel
confident that the Hugo RAS system will enable us to change that
statistic and bring the benefits of minimally invasive surgery to
more patients than ever before," said Dr. Ragavan. "I am incredibly
proud to launch this new era of possibility for our hospital and
the patients we serve with the very first clinical procedure in the
region with the Hugo RAS system."
As a form of minimally invasive surgery, robotic-assisted
surgery offers the potential for fewer complications, shorter
hospital stays, faster return to normal activities, and smaller
scars.2–4,†
"Today we're taking another exciting step forward to bring the
benefits of minimally invasive surgery to more people in more
places," said Megan Rosengarten,
president of the Surgical Robotics business, which is part of the
Medical Surgical Portfolio at Medtronic. "That's possible thanks to
a shared vision with Apollo Hospitals, the many surgeons and
hospital leaders who have partnered with us on this journey, and
our dedicated Surgical Robotics team in India and around the globe."
The Hugo RAS system — Medtronic's solution to historic cost and
utilization barriers that have kept surgical robotics out of reach
for many hospitals — is a modular, multi-quadrant platform designed
for a broad range of soft-tissue procedures. It combines
wristed instruments, 3D visualization, and Touch Surgery™
Enterprise, a cloud-based surgical video capture and management
solution, with dedicated support teams specializing in robotics
program optimization, service, and training. Earlier this year,
Medtronic announced that the first urologic and gynecologic
procedures with the Hugo RAS system took place in Latin America. Those procedures marked the
beginning of the Hugo RAS system patient registry, which is
collecting clinical data from those systems as well as the system
placed in India to support
regulatory submissions around the world.
"With the availability of the Hugo RAS system in India, we know the future of surgery is here,"
said Madan Krishnan, vice president
and managing director, India Medtronic Pvt Ltd. "Medtronic is
creating robotic-assisted surgery solutions that are optimized for
what clinicians need today and that can be upgraded as the
technology evolves and usage expands in the years to come. We're
grateful for the opportunity to partner with Apollo Hospitals on
this exciting milestone and are looking forward to collaborating in
advancing access to the latest therapies for patients."
"As the region's leading healthcare provider, we are dedicated
to bringing the very latest in medical technology to our patients,"
said Dr. Prathap C. Reddy, founder
and chairman, Apollo Hospitals Group. "The addition of the Hugo RAS
system to our robotic surgery program — and our place in history as
the first hospital in Asia-Pacific
to use this new technology — reinforces that dedication and the
pride we at Apollo Hospitals have as a premier destination for
minimally invasive surgery. This technology will complement the
excellent clinical expertise garnered by our physicians over the
years and is designed to help us enhance patient care."
"We're committed to providing the most advanced and innovative
care possible for our patients and are proud to partner with a
company that shares our values and vision," said Ms. Preetha Reddy, executive vice chairperson,
Apollo Hospitals Group. "There is an urgent need to improve
treatment options for surgeries by leveraging technology. Today,
robotic technology has come a long way, helping perform some of the
most complicated surgeries with precision, and Apollo has always
been on the forefront in bringing the most advanced technology to
India."
The Medtronic Hugo RAS system is commercially available in
certain geographies. Regulatory requirements of individual
countries and regions will determine approval, clearance, or market
availability. The Hugo RAS system is pending CE mark for the EU. In
the US, the Hugo RAS system is an investigational device not for
sale. Touch Surgery Enterprise is not intended to direct surgery,
or aid in diagnosis or treatment of a disease or condition.
For more information, visit medtronic.com/hugo.
About Apollo Hospitals
Apollo Hospitals was
established in 1983 by Dr. Prathap C Reddy, renowned as the
architect of modern healthcare in India. As the nation's first corporate
hospital, Apollo Hospitals is acclaimed for pioneering the private
healthcare revolution in the country. Apollo Hospitals has emerged
as Asia's foremost integrated
healthcare services provider and has a robust presence across the
healthcare ecosystem, including Hospitals, Pharmacies, Primary Care
& Diagnostic Clinics and several retail health models. Since
its inception, Apollo Hospitals has been honoured by the trust of
over 150 million individuals who came from 140 countries. At the
core of Apollo's patient-centric culture is TLC (Tender Loving
Care), the magic that inspires hope amongst its patients. For
further details, log onto: www.apollohospitals.com.
About Medtronic
Medtronic plc (www.medtronic.com),
headquartered in Dublin, Ireland,
is among the world's largest medical technology, services and
solutions companies – alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 90,000 people worldwide, serving physicians,
hospitals and patients in more than 150 countries. The company is
focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
†Compared to open surgery.
1. Based on internal estimates and Medtronic report, FY20 market
model: procedural volume data.
2. Fitch K, Engel T, Bochner A. Cost differences between open and
minimally invasive surgery. Managed Care. 2015
Sep;24(9):40–8.
3. Tiwari MM, Reynoso JF, High R, Tsang AW, Oleynikov D. Safety,
efficacy, and cost effectiveness of common laparoscopic procedures.
Surg Endosc. 2011;25(4):1127-1135.
4. Roumm AR, Pizzi L, Goldfarb NI, Cohn H. Minimally invasive:
minimally reimbursed? An examination of six laparoscopic surgical
procedures. Surg Innovation. 2005;12(3):261–287.
Contacts:
|
|
|
|
Gary
Jeanfaivre
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
Medtronic
plc
|
Medtronic
plc
|
+1-203-833-2104
|
+1-763-505-4626
|
|
|
Masooma
Pathre
|
Saurabh
Bose
|
Public
Relations
|
Brand and
Marcomm
|
Medtronic
India
|
Apollo
Hospitals
|
+91
9819744665
|
+91
7275798384
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/first-procedure-in-asia-pacific-performed-with-medtronic-hugo-robotic-assisted-surgery-system-301385182.html
SOURCE Medtronic plc